Escolar Documentos
Profissional Documentos
Cultura Documentos
MyChemist tops
EBOS
$18m
for
TWC
stake
satisfaction
Disadvantages integration risk, dilution, tax risk if the
ATO ratings
took a
Board seeks member
Oncology Pharmacists
w www.pharmacydaily.com.au
page 1
PHARMACYDAILY.COM.AU
www.pharmacydaily.com.au
46_emims_CRUSH_PHARAMCY_DAILY_97.5X60.indd 1
Bonus
Oli Sippy Cup
available now*
Paediatric epilepsy
med cannabis trial
Epidiolex (cannabidiol
100mg/mL oral solution) is one
of the first medicinal cannabis
pharmaceuticals to be trialled in
Queensland specifically for children
with treatment resistant epilepsy.
Researchers hope to begin
recruitment of patients for the
trial in Nov with a maximum of 30
children to be included.
Qualification criteria include
being under the care of a paediatric
neurologist as well as other
stipulations around length of
treatment and severity of disease.
Anyone who thinks they are
eligible and is interested in
participating in the trial can talk
to their treating doctor or call
13HEALTH (13 43 25 84) to register
an expression of interest.
Families will be advised if they
meet the criteria and will be invited
to take part in the trial.
t
ed a
Valu
.95
$22
w www.pharmacydaily.com.au
page 2
Advertise with us
Cost Effective
Targeted
Easy
Monday 24 Oct 2016
Weekly
Comment
Welcome to
PDs weekly
comment
feature.
This weeks
contributor is
Carl Gibson,
CMA ceo.
Complementary
medicines and evidence
THE high proportion of the
Australian population that uses
complementary medicines
(approximately 70 per cent) is
resulting in this increasingly
becoming a topic of discussion
amongst health care professionals.
One element of the discourse,
as indicated by the nature of the
questions raised in the recent
King Review discussion paper, is
that there are those who are quick
to make the blanket statement
that complementary medicines
arent supported by scientific
evidence. Not true. A quick search
of PubMed for any particular
popular herb will produce a
number of scientific studies linking
these phytotherapeutic agents to
research on a wide range of health
conditions. Many complementary
medicines have a robust evidence
base, with further analysis being
conducted on the cost effectiveness
of their use in preventative health
strategies. This is particularly the
case for major products like multi
vitamins, vitamin B and Omega-3
fatty acids, which together
account for about 50 per cent of
complementary medicines selected
for use in Australia. Healthcare
choices should be based as much
as possible on sound scientific
evidence and the fact remains
that all health disciplines need to
continue to expand their evidence
base. With continued investment in
complementary medicine research,
and the translation of evidence into
clinical practice and relevant policy,
the health of all Australians will
continue to benefit.
PHARMACYDAILY.COM.AU
Dispensary
Corner
A GLASS of red wine a day keeps
the reproductive specialist away?
The benefits of red wine have
been in the public eye before, but
now a new study by American
and Polish researchers is claiming
that a daily dose of resveratrol - a
natural compound found in red
wine - can boost womens fertility.
The study purports that
resveratrol does this by lowering
steroid hormone levels in women
who suffer from polycystic ovary
syndrome.
Maybe that explains why so
many babies are conceived after a
night out on the wines?